Medical Conditions – Page 4 – NatWonk – Dr Bier's Research Reviews

Breakfast skipping and risk of all-cause, cardiovascular and cancer mortality among adults: a systematic review and meta-analysis of prospective cohort studies

January 24, 2026

| Cancer, Cardiovascular Health, Diet & Nutrition, Longevity & Mortality

Comment: The data presented in this systematic review and meta-analysis of 242,095 participants reveals a stark collision between the biochemical promise of intermittent fasting (IF) and the hard reality of epidemiological survival. While IF is frequently promoted as a metabolic panacea—citing mechanisms like autophagy and improved insulin sensitivity—these theories often ignore the hierarchy of harm: […]

Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study

December 29, 2025

| No Comments

| Cardiovascular Health

Comment: It seems logical to assume that if elevated cholesterol increases cardiovascular risk, it must damage all vascular beds equally—threatening the brain just as much as the heart. Furthermore, most assume that the extreme elevations seen in familial hypercholesterolemia (FH) must confer a universally catastrophic risk. This study proves those assumptions wrong. This research serves […]

Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

December 27, 2025

| No Comments

| Cancer, Diet & Nutrition

Comment: This systematic review and meta-analysis is yet another high-level confirmation of a reality seen across decades of human clinical data: soy isoflavones do not possess the systemic estrogenic risks often attributed to them. In the hierarchy of research, human RCTs carry the most weight, and the aggregation of 42 randomized controlled trials here should […]

How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease

December 25, 2025

| No Comments

| Cardiovascular Health, Medications - General Pharmaceuticals

Comment: This was one of the earlier articles that really helped illustrate how important it is to keep the focus on absolute risk reduction to truly understand how effective an intervention is. Although this is a narrative review and has many risks of bias, other studies have borne out the concerns raised that the absolute […]

Malignant neoplasms in people with hypothyroidism in Spain: A population-based analysis

December 23, 2025

| No Comments

| Cancer, Medications - General Pharmaceuticals

Comment: This is another in a growing group of studies showing a correlation between levothyroxine (synthetic T4) use and increased cancer risk. What makes this analysis particularly compelling is the direct comparison between treated and untreated patients with hypothyroidism. While we must respect the limitations of observational data, we must also be pragmatic: we are […]

Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study

December 22, 2025

| No Comments

| Gastrointestinal Health, Longevity & Mortality, Medications - General Pharmaceuticals

Comment: A hazard ratio of 1.17 for all-cause mortality is a statistic that shouldn’t be ignored, but unfortunately is. It translates to 45 excess deaths for every 1,000 patients treated. But the most concerning aspect of this data is the graded relationship: the longer the exposure, the higher the risk of death. This dose-response curve […]

Iodine and Thyroid Health Synthesis

December 15, 2025

| No Comments

| Endocrine Health, Synthesis

The Wonk Debate – Audio Critique & Clinical Commentary: Synthesized Clinical Bottom Line updated 12-15-25 The relationship between iodine intake and thyroid pathology is complex, following a U-shaped curve where both deficiency and excess are detrimental. While correcting iodine deficiency is a public health priority, maintaining intake beyond “adequate” levels confers no additional clinical benefit […]

Multiple Nutritional Factors and the Risk of Hashimoto’s Thyroiditis

December 15, 2025

| No Comments

| Endocrine Health

Comment: This study suggests that the ‘dangers’ of high-dose iodine are likely overstated. For the vast majority of the population the healthy thyroid handles high iodine intake with resilience. The adverse events highlighted here likely represent a failure of supporting cofactors—specifically Selenium and Iron—rather than direct toxicity. These nutrients act as the ‘safety valves’ for […]

Excess iodine intake: sources, assessment, and effects on thyroid function

December 14, 2025

| No Comments

| Endocrine Health

Comment: It is ‘common knowledge’ that higher iodine supplementation is dangerous. However this review clearly shows the distinction between the ‘healthy majority’ and the ‘vulnerable minority.’ While most individuals possess a robust capacity to handle high iodine loads (via the Wolff-Chaikoff escape mechanism), the data here is a reminder that doesn’t apply for specific subgroups. […]

Iodine Excess as an Environmental Risk Factor for Autoimmune Thyroid Disease

December 14, 2025

| No Comments

| Endocrine Health

Comment: This review convincingly details how excess iodine drives autoimmunity at a molecular level, establishing a strong case for biological plausibility. However, it leaves us with significant uncertainty regarding when this becomes a clinical reality. Because the authors rely on a narrative overview rather than a systematic quantitative synthesis, It remains difficult to determine if […]